Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GMRE Global Medical REIT Inc
- Stocks
- Real Estate
- NYSE: GMRE
Price (delayed)
$6.354
Market cap
$424.95M
P/E Ratio
211.8
Dividend/share
$0.84
EPS
$0.03
Enterprise value
$1.09B
Global Medical REIT Inc. is a net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market
Highlights
The EPS has surged by 200% since the previous quarter but it has dropped by 87% year-on-year
The company's net income has shrunk by 62% YoY but it rose by 20% QoQ
The equity has declined by 10% year-on-year and by 3.1% since the previous quarter
GMRE's debt is up by 10% YoY and by 4.8% QoQ
Sector: Real Estate
Industry: REIT - Healthcare Facilities
Website: http://www.globalmedicalreit.com
Key stats
What are the main financial stats of GMRE
Market
Valuations
Earnings
Shares outstanding
66.88M
Market cap
$424.95M
Enterprise value
$1.09B
Price to earnings (P/E)
211.8
Price to book (P/B)
0.82
Price to sales (P/S)
3.07
EV/EBIT
29.65
EV/EBITDA
14.12
EV/Sales
7.91
Revenue
$138.28M
Gross profit
$138.28M
Operating income
$33.27M
Net income
$7.94M
EBIT
$36.91M
EBITDA
$77.53M
Free cash flow
$5M
Per share
Balance sheet
Liquidity
EPS
$0.03
EPS diluted
$0.03
Free cash flow per share
$0.07
Book value per share
$7.74
Revenue per share
$2.07
TBVPS
$18.9
Total assets
$1.27B
Total liabilities
$731.45M
Debt
$677.03M
Equity
$517.35M
Working capital
N/A
Debt to equity
1.31
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
8.63
Margins
Efficiency
Dividend
EBITDA margin
56.1%
Gross margin
100%
Net margin
5.7%
Operating margin
24.1%
Return on assets
0.2%
Return on equity
0.4%
Return on invested capital
2%
Return on capital employed
N/A
Return on sales
26.7%
Dividend yield
13.22%
DPS
$0.84
Payout ratio
2,800%
GMRE stock price
How has the Global Medical REIT stock price performed over time
Intraday
2.48%
1 week
-3.87%
1 month
-17.37%
1 year
-28.61%
YTD
-17.69%
QTD
-27.38%
Financial performance
How have Global Medical REIT's revenue and profit performed over time
Revenue
$138.28M
Gross profit
$138.28M
Operating income
$33.27M
Net income
$7.94M
Gross margin
100%
Net margin
5.7%
The company's net income has shrunk by 62% YoY but it rose by 20% QoQ
GMRE's net margin has shrunk by 61% YoY but it is up by 19% QoQ
GMRE's operating income is down by 11% year-on-year
The operating margin is down by 9% year-on-year
Price vs fundamentals
How does GMRE's price correlate with its fundamentals
Growth
What is Global Medical REIT's growth rate over time
Valuation
What is Global Medical REIT stock price valuation
P/E
211.8
P/B
0.82
P/S
3.07
EV/EBIT
29.65
EV/EBITDA
14.12
EV/Sales
7.91
The EPS has surged by 200% since the previous quarter but it has dropped by 87% year-on-year
The P/B is 33% lower than the 5-year quarterly average of 1.2 and 27% lower than the last 4 quarters average of 1.1
The equity has declined by 10% year-on-year and by 3.1% since the previous quarter
The stock's price to sales (P/S) is 48% less than its 5-year quarterly average of 5.8 and 29% less than its last 4 quarters average of 4.2
Efficiency
How efficient is Global Medical REIT business performance
GMRE's ROA has soared by 100% QoQ but it has shrunk by 83% YoY
The ROE has shrunk by 84% YoY
The return on sales has declined by 26% year-on-year but it rose by 4.7% since the previous quarter
GMRE's return on invested capital is down by 26% year-on-year but it is up by 5% since the previous quarter
Dividends
What is GMRE's dividend history
DPS
$0.84
Dividend yield
13.22%
Payout ratio
2,800%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Global Medical REIT financials performed over time
The company's total assets is 74% higher than its total liabilities
The total liabilities is up by 10% year-on-year and by 4.4% since the previous quarter
GMRE's debt is 31% higher than its equity
The debt to equity rose by 22% year-on-year and by 8% since the previous quarter
The equity has declined by 10% year-on-year and by 3.1% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.